QUMEA, a digital health firm based in the canton of Solothurn, has raised 9 million Swiss francs as part of a Series A financing round. According to a press release, the group of investors includes the cantonal bank of Zurich, Zürcher Kantonalbank (ZKB), PB Invest Schweiz and two family offices. The financing round also includes a non-dilutive growth loan from the major Swiss bank UBS.
“We are grateful to have had multiple options for this financing round”, comments Cyrill Gyger, CEO of QUMEA, in the press release. From his point of view, this is not something that can be taken for granted in the current financing landscape. “We chose an investor structure that perfectly aligns with our values and long-term strategy”, he adds. QUMEA is now “perfectly positioned to replicate our Swiss success in international markets”.
The QUMEA system has already been deployed successfully across several European countries. The palm-sized radar sensor can be affixed to the ceiling to communicate with medical staff via a smartphone app or the patient call system.
The system uses algorithms developed on the basis of Artificial Intelligence (AI) to interpret the signals from a radar sensor that records a patient’s movements throughout a whole room. If a patient at risk of falling tries to get out of bed, medical staff are immediately informed so that they can intervene preventively and supportively. This also helps to avoid pressure ulcers caused by bed sores more easily.
“Our decision to invest with our scale-up ticket reflects our belief in QUMEA’s extraordinary market-fit and its potential to disrupt an important segment of the healthcare sector”, comments Yves Becker, Senior Investment Manager at ZKB, in the press release.
